Plunkett Research Online: US Stem Cell Inc

US STEM CELL INC (USRM:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

U.S. Stem Cell, Inc. discovers, develops and commercializes autologous cell therapies (cells derived from the patient’s own body) for the treatment of chronic and acute heart damage. The company is also a regenerative medicine company specializing in physician/veterinary training and certification .....



US Stem Cell Inc
Ticker: USRM
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 954 835-1500
Fax: 954 845-9976
Address: 13794 North West 4th Street
Suite 212
Sunrise, FL 33325 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Research & Development-Heart-Related Therapies
ContactsDescription
Mike TomasCEO/CFO/Chief Accounting Officer/Director/President
William MurphyChairman of the Board/Director
See More
U.S. Stem Cell, Inc. discovers, develops and commercializes autologous cell therapies (cells derived from the patient’s own body) for the treatment of chronic and acute heart damage. The company is also a regenerative medicine company specializing in physician/veterinary training and certification .....See More See More

Auditor: Fiondella, Milone & LaSaracina LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
MyoCell
MyoCell SDF-1
AdipoCell
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: